Treating type 2 diabetes: moving towards precision medicine
Open Access
- 22 November 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Digital Health
- Vol. 4 (12) , e851-e852
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort studyThe Lancet Digital Health, 2022
- Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registersAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2022
- Standards of Medical Care in Diabetes—2022 Abridged for Primary Care ProvidersClinical Diabetes, 2022
- Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 UpdateCanadian Journal of Diabetes, 2020
- Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complicationsDiabetes & Metabolism, 2019
- Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted TrendsJournal of Epidemiology and Global Health, 2019
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes Care, 2018